PubMed Journals Articles About "Medicare Part Consolidation Will Only Worse With Proposed" RSS

15:35 EST 22nd January 2019 | BioPortfolio

Medicare Part Consolidation Will Only Worse With Proposed PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Medicare Part Consolidation Will Only Worse With Proposed articles that have been published worldwide.

More Information about "Medicare Part Consolidation Will Only Worse With Proposed" on BioPortfolio

We have published hundreds of Medicare Part Consolidation Will Only Worse With Proposed news stories on BioPortfolio along with dozens of Medicare Part Consolidation Will Only Worse With Proposed Clinical Trials and PubMed Articles about Medicare Part Consolidation Will Only Worse With Proposed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medicare Part Consolidation Will Only Worse With Proposed Companies in our database. You can also find out about relevant Medicare Part Consolidation Will Only Worse With Proposed Drugs and Medications on this site too.

Showing "Medicare Part consolidation will only worse with proposed" PubMed Articles 1–25 of 13,000+

Cornered: Proposed Medicare Fee Overhaul Could Box In Doctors.

Proposed overhaul to Medicare payments for complex patient care visits and same-day office-based procedures could box in Texas physicians.

Variation in Prostaglandin Analog Prices Paid for Through Medicare Part D.

Determine the prices and price variation of the prostaglandin analogs (PGAs) used in the United States and examine their trends from 2013-2016 using Medicare Part D data.

Scopolamine does not Impact Declarative and Motor Memory Consolidation Across a Night of Sleep or a Day of Wakefulness.

It has been proposed that normal waking levels of acetylcholine (ACH) are important for initial memory acquisition, and that decreased ACH is critical for memory consolidation. Sleep is thought to benefit memory consolidation in part due to the predominance of low ACH levels observed during non-rapid eye movement sleep. Here we examined whether sleep and ACH suppression with the cholinergic antagonist scopolamine impact declarative and motor memory consolidation across a night of sleep or a day of wakefulne...

County-level access to opioid use disorder medications in medicare Part D (2010-2015).

To identify geographic disparities in access to opioid use disorder (OUD) treatment medications and county demographic and economic characteristics associated with access to buprenorphine and oral naltrexone prescribers in Medicare Part D.

Trends in Medicare Utilization by Dermatologists, 2012-2015.

Medicare represents the second largest component of national health expenditures, and dermatologists receive a disproportionate percentage of Medicare payments. Analyzing trends in Medicare utilization by dermatologists informs optimal Medicare usage for both patients and physicians.

Identifying Observation Stays In Medicare Data: Policy Implications of a Definition.

Observation stays are increasingly common, yet no standard method to identify observation stays in Medicare claims is available, including events with status change. To determine the claims patterns of Medicare observation stays, define comprehensive claims-based methodology for future Medicare observation research and data reporting, and identify policy implications of such definition, we identified potential observation events in a 2014 20% random sample of Medicare beneficiaries with both Part A and B cl...

Simplifying The Medicare Plan Finder Tool Could Help Older Adults Choose Lower-Cost Part D Plans.

Helping older adults make good plan choices is a persistent challenge of the Medicare prescription drug (Part D) program. The Centers for Medicare and Medicaid Services (CMS) provides an internet-based decision support tool (Plan Finder), but this appears to have had limited effect in part because the tool is complex and difficult to interpret. This study used a randomized experiment with hypothetical Part D plan choices to test the effect of simplifying the default amount of financial information provided ...

Do Medicare Advantage Plans Respond to Payment Changes? A Look at the Data from 2009 to 2014.

Medicare Advantage (MA) enrollment has grown significantly since 2009, despite legislation that reduced what Medicare pays these plans to provide care to enrollees. MA payments, on average, now approach parity with costs in traditional Medicare.

Prices for physician services in Medicare Advantage versus traditional Medicare.

To compare the prices paid to physicians by employer-sponsored Medicare Advantage (MA) plans with those paid by traditional Medicare (TM) and to determine whether the relationship between MA and TM prices is affected by the generosity of MA benchmarks.

Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015.

Access to prescription medications is critical as the U.S. population ages. Escalating drug costs have garnered mounting attention from the public with increasing federal scrutiny. The Medicare Part D program will increasingly be relied upon to support the health of our nation's older people. We reviewed the publically available Medicare Part D usage data from 2011 to 2015 to quantify the cost of the 10 costliest medications for Part D, evaluated the number of beneficiaries treated with these medications, a...

Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket Cap.

Medicare Part D has no cap on beneficiaries' out-of-pocket spending for outpatient prescription drugs, and, unlike Medicare Parts A and B, beneficiaries are prohibited from purchasing supplemental insurance that could provide such a cap. Historically, most beneficiaries whose annual Part D spending reached the catastrophic level were protected from unlimited personal liability by the Low-Income Subsidy (LIS). However, we found that the proportion of beneficiaries whose spending reached that level but did no...

FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression.

On January 1, 2018, Medicare Part D insurers implemented a new rule that seriously affects immunosuppression in lung transplant recipients. The program is now following the directive of the US Food and Drug Administration (FDA) that no drug should be dispensed or be covered by insurance for any indications other than those approved by the FDA (1, 2). That excludes the use of mycophenolate (CellCept and Myfortic) and azathioprine (Imuran) for lung transplant recipients. This new rule affects not only patient...

Effects of Extracorporeal Shock Wave Therapyon Distraction Osteogenesis in Rat Mandible.

Distraction osteogenesis (DO) has widespread clinical use in the treatment of congenital and acquired craniofacial deformities. Nonetheless, during the prolonged consolidation period, the newly regenerated bone carries the risk of complications. One of the proposed methods to enhance bone healing and shorten the consolidation period is extracorporeal shock wave therapy (ESWT). In the field of orthopedics, ESWT has been shown to induce neovascularization and promote tissue regeneration. We investigated wheth...

National Performance on the Medicare SEP-1 Sepsis Quality Measure.

The Centers for Medicare and Medicaid Services requires hospitals to report compliance with a sepsis treatment bundle as part of its Inpatient Quality Reporting Program. We used recently released data from this program to characterize national performance on the sepsis measure, known as SEP-1.

Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Extension of Temporary Moratoria on Enrollment of Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Designated Geographic Locations. Extension of temporary moratoria.

This document announces the extension of statewide temporary moratoria on the enrollment of new Medicare Part B non-emergency ground ambulance providers and suppliers and Medicare home health agencies and branch locations in Florida, Illinois, Michigan, Texas, Pennsylvania, and New Jersey, as applicable, to prevent and combat fraud, waste, and abuse. This extension also applies to the enrollment of new non- emergency ground ambulance suppliers and home health agencies and branch locations in Medicaid and ...

Disparities in Low-Vision Device Use Among Older US Medicare Recipients.

Low-vision assistive devices are not covered by Medicare and many private insurers, although there is evidence that they can improve functioning and quality of life. Little is known about whether sociodemographic disparities exist in the use of low-vision services by Medicare beneficiaries.

Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D.

Medicare Utilization and Spending Among Nurses Compared with the General United States Population.

To better understand health habits in older nurses versus the general population, we sought to determine whether the demographics, health care utilization, and Medicare spending by the Nurses' Health Study (NHS) participants enrolled in Medicare and a matched sample of Medicare beneficiaries meaningfully differed.

Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.

Annual influenza vaccination campaigns emphasize the importance of getting vaccinated against influenza. These campaigns offer potential opportunities to raise awareness of all vaccines. We explored the peak timing of the receipt of influenza and other routinely recommended vaccinations. We examined administrative claims data of 31 million Medicare fee-for-service beneficiaries, eligible to receive vaccinations administered from 2013 to 2015 from Medicare Part B (medical insurance) and Medicare Part D (pres...

Health care in a multi-payer system: Spillovers of health care service demand among adults under 65 on utilization and outcomes in medicare.

This paper examines, theoretically and empirically, how changes in the demand for health insurance and medical services in the non-Medicare population - coverage eligibility changes for parents and the firm size composition of employment - spill over and affect health insurance coverage and how these factors affect per beneficiary Medicare spending. We find that factors that increase coverage and hence demand for medical services in the non-Medicare population generate contemporaneous decreases in per benef...

Why Medicare Advantage enrollment will keep on growing, whatever the politics.

In 2019, a record 36% of Medicare beneficiaries will be getting their benefits in a Medicare Advantage plan. CMS has broadened the services such plans can provide-services that may reduce expensive treatments and injuries. Insurers continue to see the market as a business opportunity. Critics see a slow-motion privatization of the entitlement.

Regional Variations: The Use Of Hospitals, Home Health, And Skilled Nursing In Traditional Medicare And Medicare Advantage.

In the traditional Medicare program, the use of health care services-particularly postacute care-varies substantially across geographic regions. Less is known about such variations in Medicare Advantage (MA), which is growing rapidly. Insurers that are paid on a risk basis, as in MA, may have incentives and tools to restrain the use of services, which could attenuate geographic variations. In this study of fifty-four million Medicare beneficiaries in the period 2007-13, we found that geographic variations i...

New Medicare Diabetes Prevention Coverage May Limit Beneficiary Access and Widen Health Disparities.

The Centers for Medicare and Medicaid Services recently issued final rules for the Medicare Diabetes Prevention Program (MDPP), offering an unprecedented opportunity to provide lifestyle intervention to Medicare beneficiaries with prediabetes via a pay-for-performance model. The MDPP is based on the widely disseminated, yearlong National Diabetes Prevention Program (NDPP), which has lesser but still beneficial risk-reduction outcomes among minority and low-income participants.

The financial impact of the sequester cut to Medicare Part B drug reimbursement in community oncology.

Differences in Hospitalizations Between Fee-For-Service and Medicare Advantage Beneficiaries.

Previous studies found lower hospitalization rates for enrollees in Medicare Advantage (MA) plans than for beneficiaries with Fee-For-Service (FFS) coverage. MA enrollment is increasing, especially for those newly eligible for Medicare, but little is known about how service use in FFS or MA differs for new beneficiaries.

Quick Search